Fondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Single Dose, Prefilled Syringe, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520. Made in India. NDC 55150-232-10 (carton)NDC 55150-232-00 (syringe)
Published November 2, 2022 · Recall initiated: September 30, 2022
Summary
FDA records drug Class II recall D-0020-2023, published November 2, 2022 and initiated September 30, 2022. Recalling firm: AuroMedics Pharma LLC; Status: Terminated; Reported quantity: 11,520 units; Lot: Lot # CFN200020, EXP Nov. 2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug: Out of specification for assay
What to do
Voluntary: Firm initiated · Letter
Get an email if FONDAPARINUX SODIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- FONDAPARINUX SODIUM
- Manufacturer
- AuroMedics Pharma LLC
- Distributor
- Nationwide in the USA
- Lot
- Lot # CFN200020, EXP Nov. 2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAtenolol Tablets, USP, 25 mg, 1000-count bottle, Rx only, Manufactured by: ALPHAPHARM PTY LTD, Marketed by:November 2, 2022
- FDAQuinapril and Hydrochlorothiazide Tablets, USP 20mg/12.5mg, 90 Tablets bottles Distributed by: AurobindoNovember 2, 2022
- FDAPyridostigmine Bromide Oral Solution, USP 60 mg/5 mL Delivers 5 mL, packaged in 5mL unit-dose cup, Rx only,November 2, 2022
- FDA8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons ofNovember 2, 2022
- FDAProton Armor, Anti-Microbial Alcohol-Free Foaming Hand Sanitizer, kills 99.99% of germs, Green Tea and Aloe,November 2, 2022
- FDA8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons ofNovember 2, 2022
Questions about this recall
Was Fondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Single Dose, Prefilled Syringe, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520. Made in India. NDC 55150-232-10 (carton)NDC 55150-232-00 (syringe) recalled?
Yes. FDA published recall D-0020-2023 on November 2, 2022. Reported hazard: Subpotent Drug: Out of specification for assay
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: FONDAPARINUX SODIUM.